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Oxygen uptakeJuglone is a phenolic compound used in popular medicine as a phytotherapic to treat inﬂammatory and
infectious diseases. However, it also acts as an uncoupler of oxidative phosphorylation in isolated liver mito-
chondria and, thus, may interfere with the hepatic energy metabolism. The purpose of this work was to eval-
uate the effect of juglone on several metabolic parameters in the isolated perfused rat liver. Juglone, in the
concentration range of 5 to 50 μM, stimulated glycogenolysis, glycolysis and oxygen uptake. Gluconeogenesis
from both lactate and alanine was inhibited with half-maximal effects at the concentrations of 14.9 and
15.7 μM, respectively. The overall alanine transformation was increased by juglone, as indicated by the stim-
ulated release of ammonia, urea, L-glutamate, lactate and pyruvate. A great increase (9-fold) in the tissue con-
tent ofα-ketoglutarate was found, without a similar change in the L-glutamate content. The tissue contents of
ATP were decreased, but those of ADP and AMPwere increased. Experiments with isolated mitochondria fully
conﬁrmed previous notions about the uncoupling action of juglone. It can be concluded that juglone is active
on metabolism at relatively low concentrations. In this particular it resembles more closely the classical un-
coupler 2,4-dinitrophenol. Ingestion of high doses of juglone, thus, presents the same risks as the ingestion of
2,4-dinitrophenol which comprise excessive compromising of ATP production, hyperthermia and even death.
Low doses, i.e., moderate consumption of natural products containing juglone, however, could be beneﬁcial
to health if one considers recent reports about the consequences of chronic mild uncoupling.KetoC, cytosolicα-ketoglutarate;
oglutarate; GluM,mitochondrial
rboxylic acid cycle; ALT, alanine
cytosolic isocitrate; LDH, lactate
IDHM, mitochondrial isocitrate
istry, University of Maringá,
vier OA license. © 2011 Elsevier Inc. Open access under the Elsevier OA license. Introduction
Juglone (5-hydroxy-1,4-naphthoquinone) is a phenolic compound
with allelopathic properties belonging to the class of naphthoqui-
nones. Its chemical structure is shown in Fig. 1. This quinone is
found in roots, leaves, bark and nuts of several species of walnut
from the plant family Juglandaceae (Lee and Campbell, 1969). The
α-hydrojuglone is the reduced form of juglone and is related to devel-
opmental processes and defense mechanisms of the nuts. When
exposed to the air, the α-hydrojuglone is readily oxidized to juglone
(Duroux et al., 1998; Rietveld, 1983).
The extract of walnut is widely used in popular medicine as a phy-
totherapic to treat inﬂammatory diseases, eczema, acne, herpes, psoria-
sis, and bacterial, fungal, viral and parasitic diseases (Bell, 1981; Jin,2010;Mahoney et al., 2000). On the other hand, juglone has been inves-
tigated by the National Toxicology Program (USA) as a potentially toxic
natural product (Mahoney et al., 2000). The naphthoquinones can cause
a variety of hazardous effects in vivo, including acute cytotoxicity and
immunotoxicity (Bolton et al., 2000). The mechanisms by which
juglone causes cell toxicity are complex. This is partly caused by the
fact that juglone can assume three structures which are in equilibrium:
in addition to the oxidized and fully reduced forms shown in Fig. 1, the
partially reduced semiquinone is also usually present. The mechanisms
of action of juglone comprisemixed actionswhich include the reactivity
of the electrophilic quinoidal group and the ability to undergo oxida-
tion–reduction cycleswith concomitant formation of free radicals (Dur-
oux et al., 1998; O'Brien, 1991; Rath et al., 1996). Juglone can also
interact with nucleophilic biomolecules such as glutathione and thiol
groups of proteins which lead to the oxidation of nucleophilic sites.
This, in turn, causes inactivation of enzymes or cellular signaling pro-
teins (Klaus et al., 2010).
The toxicity of juglone on bacteria is attributed to changes in the
plasma membrane (Zhang et al., 1994). In human lymphocytes,
50 μM juglone inhibits cell proliferation by blocking potassium chan-
nels. In consequence it induces polarization of the plasma membrane
(Varga et al., 1996). The juglone also appears to inhibit enzymes such
as protein kinase C (Frew et al., 1995) and cytochrome P450 aromatase
in human placental microsomes in a dose-dependent manner (Muto
Fig. 1. Chemical formulae of α-hydrojuglone and juglone.
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reduces protein levels and induces cell death (Paulsen and Ljungman,
2005). In addition, juglone interferes with cellular energy metabolism
due its uncoupling of mitochondrial oxidative phosphorylation. On
this respect, Makawiti et al. (1990) reported preliminary experiments
which strongly suggest that juglone is able to uncouple rat liver
mitochondria.
As it occurs with most xenobiotics, juglone also undergoes hepatic
biotransformation, primarily reduction reactions and conjugation
with sulfate and glucuronic acid to form various metabolites which
are excreted mainly into urine (Chen et al., 2005). The compound
has thus clearly full access to the liver cells and several metabolites
are generated, some of which are also potentially toxic. Due to its
uncoupling action detected with isolated mitochondria (Makawiti et
al., 1990), it is highly probable that this activity will manifest itself
when the compound is used for medicinal purposes. For this reason
it is also of great interest to evaluate the possible effects that juglone
might have on the liver functions that are energy-dependent or that
are linked in some way to energy metabolism. To investigate these
effects was exactly the purpose of the present study. The isolated
perfused rat liver was used, because this system allows to measure
several related processes such as oxygen consumption, glycolysis,
gluconeogenesis and ureogenesis, which are linked to energy metab-
olism. Experiments with isolated mitochondria were also done in
order to present conﬁrmative evidence and to complement previous
reports (Makawiti et al., 1990). The results should improve our
understanding of the action mode of juglone on mammalian cells and
to help in the decision of using or not the compound as a therapeutic
agent.
Materials and methods
Materials. The liver perfusion apparatus was built in the workshops
of the University of Maringa. Juglone, enzymes and coenzymes used
in the enzymatic assays were purchased from Sigma-Aldrich Co (St.
Louis, USA). All other chemicals were from the best available grade
(98–99.8% purity) and were purchased from Sigma-Aldrich, Merck (Dar-
mstad, FRG) and Reagen (Rio de Janeiro, Brazil).
Animals. Male Wistar rats weighing 200–280 g were used in all ex-
periments. Animals were fed ad libitum with a standard laboratory
diet (Nuvilab®, Colombo, Brazil) and maintained on a regulated
light–dark cycle. In accordance with protocol, rats were used fed or
starved for 18 h prior to the experiments. For the surgical procedure,
the rats were anesthetized by intraperitoneal injection of sodium
thiopental (50 mg/kg). The criterion of anesthesia was the lack of
body or limb movement in response to a standardized tail clamping
stimulus. All experiments were done in accordance with the world-
wide accepted ethical guidelines for animal experimentation.
Liver perfusion. Hemoglobin-free, non-recirculating perfusion was
performed according to the technique described by Scholz and
Bücher (1965). After cannulation of the portal and cava veins the
liver was positioned in a plexiglass chamber. The constant ﬂow was
provided by a peristaltic pump (Minipuls 3, Gilson, France) and wasadjusted between 30 and 32 mL/min, depending on the liver weight.
The perfusion ﬂuid was Krebs/Henseleit-bicarbonate buffer (pH 7.4)
containing 25 mg% bovine-serum albumin, saturated with a mixture
of oxygen and carbon dioxide (95:5) by means of a membrane oxy-
genator with simultaneous temperature adjustment (37 °C). The
composition of the Krebs/Henseleit-bicarbonate buffer is the follow-
ing: 115 mM NaCl, 25 mM NaHCO3, 5.8 mM KCl, 1.2 mM Na2SO4,
1.18 mM MgCl2, 1.2 mM NaH2PO4 and 2.5 mM CaCl2. The perfusion
ﬂuid enters the liver via a cannula inserted into the portal vein and
leaves the organ via a cannula inserted into the cava vein (Scholz
and Bücher, 1965). Samples of the efﬂuent perfusion ﬂuid were col-
lected and analyzed for their metabolite contents. Substrates and
drugs were added to the perfusion ﬂuid according to the experimen-
tal protocols. Due to its low water solubility, juglone was added to the
perfusion ﬂuid as a dimethylsulfoxide solution to achieve the desired
ﬁnal concentration. It is already amply documented that
dimethylsulfoxide does not signiﬁcantly affect liver metabolism, at
least not when infused at rates up to 32 μL/min (Acco et al., 2004), a
limit that was never surpassed in the present work.
Analytical. In the efﬂuent perfusion ﬂuid the following compounds
were assayed by means of standard enzymatic procedures: glucose,
lactate, pyruvate, ammonia, urea and glutamate (Bergmeyer, 1974).
The oxygen concentration in the outﬂowing perfusate was monitored
continuously, employing a teﬂon-shielded platinum electrode ade-
quately positioned in a plexiglass chamber at the exit of the perfusate
(Scholz and Bücher, 1965). Metabolic rates were calculated from
input–output differences and the total ﬂow rates and were referred
to the wet weight of the liver.
For measuring the hepatic contents of glutamate, α-ketoglutarate
and adenine nucleotides (AMP, ADP, ATP, NAD+ and NADH) the per-
fused livers were frozen in liquid nitrogen and extracted. The acid-
stable adenine nucleotides (AMP, ADP, ATP and NAD+), glutamate
and α-ketoglutarate were extracted with a 0.6 M perchloric acid solu-
tion. After mixing the liver powder with 3 volumes of the perchloric
acid solution the suspension was homogenized in a Van-Potter
homogenizer. The homogenate was centrifuged for 10 min at 3000 g
(2 °C) and the supernatant was neutralized with potassium carbonate.
Alpha-ketoglutarate and glutamate in the neutralized extract were
determined by enzymatic procedures (Bergmeyer, 1974) and the
adenine nucleotides by high-performance liquid chromatography
(HPLC) analysis.
The acid-labile NADH was extracted with alkali. Two grams of the
frozen tissue were suspended in a water–ethanol mixture (1:1) con-
taining 0.5 M KOH in a centrifuge tube previously cooled in ice. The
tubes were closed and maintained in bath at 90 °C for 5 min. After
more 5 min, triethanolamine-phosphate buffer (0.5 M triethanola-
mine+0.4 M KH2PO4+0.1 M K2HPO4) was added and the suspen-
sion was neutralized with HCl (5 M). After 10 min at room
temperature the neutralized suspension was centrifuged for 5 min
at 30,000 g (2 °C) and the supernatant was used for NADH assay by
HPLC.
The HPLC system (Shimadzu, Japan) consisted in a system controller
SCL-10AVP, two pumps model LC10AVDP, a column oven model CTO-
10AVP, and a UV–VIS detector model LC10AVP. A reversed-phase
column C18 HRC-ODS (5 lm; 150·6 mm I.D.; Shimadzu, Japan), pro-
tected with a pre-column GHRC-ODS (5 μm; 10·4 mm I.D.; Shimadzu,
Japan), was used with a gradient from reversed-phase 0.044 M
phosphate buffer solution pH 6.0 to 0.044 M phosphate buffer solution
plus methanol (1.1) pH 7.0 at 0.8 mLmin−1. The gradient was (in% of
methanol): 0 min, 0%; 2.5 min, 0.5%; 5 min, 3%; 7 min, 5%; 8 min, 12%;
10 min, 15%; 12 min, 20%; 20 min, 30%. Temperature was kept at
35 °C and the injection volume was always 20 μL. The UV-absorbance
detector was auto-zeroed at the start of each chromatogram and the
absorbance was measured at 254 nm for the perchloric acid extract
and 340 nm for the KOH extract.
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carried out by comparison of their retention times with those obtained
injecting standards in the same conditions, as well as by spiking liver
samples with stock standard solutions. The concentrations of the iden-
tiﬁed compounds in the extract samples were calculated by means of
the regression parameters obtained from calibration curves. The cali-
bration curves were constructed by separating chromato-graphically
standard solutions of the compounds. Linear relationships were
obtained between the concentrations and the areas under the absor-
bance curves.
Mitochondria isolation and measurement of respiratory activity. Fed
rats were decapitated and their livers removed immediately and
placed in ice-cold buffer containing 200 mM mannitol, 75 mM su-
crose, 0.2 mM ethylene glycol tetraacetic acid (EGTA), 2 mM tris
(hydroxymethyl)amino-methane (Tris–HCl), pH 7.4 and 50 mg%
bovine serum albumin. The tissue was minced, washed with the buffer
and homogenized in the samemedium bymeans of a Dounce homoge-
nizer for lysing the cells. After homogenization, the mitochondria were
isolated by differential centrifugation (Bracht et al., 2003; Voss et al.,
1961) and suspended in the same medium, which was kept at 0–4 °C.
Oxygen uptake by isolated mitochondria was measured polaro-
graphically using a teﬂon-shielded platinum electrode (Clark, 1956;
Voss et al., 1961). Mitochondria (0.90±0.20 mg protein/mL) were
incubated in the closed oxygraph chamber in a medium (2.0 mL)
containing 0.25 M mannitol, 5 mM sodium diphosphate, 10 mM KCl,
0.2 mM ethylenediamine tetraacetic acid (EDTA), 25 mg% fatty acid-
free bovine serum albumin, 10 mM Tris–HCl (pH 7.4) and two differ-
ent substrates in addition to various juglone concentrations in
the range between 1 and 10 μM. The substrates were succinate and
β-hydroxybutyrate, both at a concentration of 10 mM. ADP, for a
ﬁnal concentration of 0.125 mM, was added at appropriate times.
Rates of oxygen uptake were computed from the slopes of the recorder
tracings and expressed as nmolmin−1 (mg protein)−1. The respiratory
control ratio (RC) and the ADP/O ratio were calculated according to
Chance and Williams (1955).
Protein content of the mitochondrial suspensions was measured by
the method described by Lowry et al. (1951), using the folin-phenol
reagent and bovine serum albumin as standard.
Membrane-bound enzyme activities. The mitochondrial ATPase activ-
ity was measured in intact (coupled and uncoupled) and in freeze-
thawing disrupted mitochondria according to the protocol of Bracht et
al. (2003) with modiﬁcations. Intact mitochondria (1.0 mg protein/mL)
were incubated in a medium containing 0.2 M sucrose, 50 mM KCl, and
10 mM Tris–HCl (pH 7.4) plus 0.2 mM EGTA and 5.0 mM ATP for
20 min, at 37 °C, in the absence (coupled) and presence (uncoupled) of
0.2 mM 2,4-dinitrophenol (DNP), in a ﬁnal volume of 0.5 mL. When
disrupted mitochondria were used as enzyme source, the medium con-
tained 20 mMTris–HCl (pH 7.4). The reactionwas started by the addition
of 5 mM ATP and stopped by the addition of ice-cold 5% trichloroacetic
acid. ATPase activity was evaluated by measuring the released inorganic
phosphate as described by Fiske and Subbarow (1925) at 700 nm.
Freeze-thawing-disrupted mitochondria were used as enzyme
source for assaying NADH and succinate oxidases. The activity of the
enzymes was measured polarographically using a 20 mM Tris–HCl
(pH 7.4) medium. The reaction was started by the addition of
substrates, 1 mM NADH and 1 mM succinate, for NADH oxidase and
succinate oxidase, respectively.
Transaminase activities in the liver homogenate. For the determina-
tion of alanine aminotransferase (ALT) and aspartate aminotransferase
(AST) the livers were surgically removed from anesthetized rats and ho-
mogenized in a Dounce type homogenizer. The resulting homogenate
was centrifuged at 105,000 g for 30 min. The supernatant of this centrifu-
gation was used as enzyme source. Standard commercial Kits (GoldAnalisa Diagnóstica Ltda®, Belo Horizonte, Brazil) were used for AST
and ALT determination. Juglone was added directly to the reaction medi-
um at the desired concentrations.
Statistical analysis. The error parameters presented in graphs and
tables are standard errors of the means. Statistical analysis was per-
formed by means of the GraphPad Prism Software (version 5.0). Var-
iance analysis was done with post-hoc Student-Newman–Keuls
testing. The 5% level (pb0.05) was adopted as a criterion of
signiﬁcance.
Results
Effects of juglone on glycogen catabolism and glycolysis
The ﬁrst experiments were planned for testing possible effects of
juglone on glycogen catabolism and glycolysis. Livers from fed rats
when perfused with substrate-free medium survive at the expense
of glycogen degradation via glycolysis and oxidation of endogenous
fatty acids (Scholz and Bücher, 1965). Under these conditions the
livers release glucose, lactate and pyruvate as a result of glycogen
catabolism. Fig. 2A illustrates the responses of perfused livers to
juglone infusion at the concentration of 50 μM. It also illustrates a
typical experimental protocol, which was used for all other juglone
concentrations. After a pre-perfusion period of 10 min, juglone was
infused during 30 min, followed by additional 20 min of drug-free
perfusion. Four parameters were measured: glucose release, lactate
and pyruvate productions and oxygen consumption. As revealed by
Fig. 2A all parameters were stable before the initiation of juglone
infusion. Upon juglone infusion, oxygen uptake increased and
remained so during the entire infusion period. Glucose release was
increased with a peak value 50% above the basal values. Lactate pro-
duction was also increased with peak values 60% above the basal
rates. Pyruvate production increased slowly and at the end of the
juglone infusion (40 min perfusion time) it was 90% above the basal
value. After removing the drug from the perfusion liquid, stimulations
of oxygen consumption and pyruvate production were maintained
for at least 20 min, but glucose release and lactate production
returned to their basal levels.
Experiments like those illustrated in Fig. 2A were repeated with 10
and 20 μM juglone in order to establish concentration dependences
for the effects. The mean values for each parameter at the end of
the juglone infusion period (40 min perfusion time) were evaluated.
Oxygen consumption, glycogenolysis [glucose release plus ½(pyru-
vate plus lactate productions)] and glycolysis (pyruvate plus lactate
productions) were represented against the juglone concentration in
Fig. 2B. All stimulations present saturation, with little changes after
20 μM juglone. In Fig. 2C, the lactate to pyruvate ratio, an indicator
for the cytosolic NADH/NAD+ ratio (Scholz and Bücher, 1965), was
plotted against the drug concentration. Juglone up to 20 μM increased
the NADH/NAD+ ratio, but with 50 μM it returned to the value in the
absence of juglone.
Effects of juglone on gluconeogenesis and ureogenesis
Since juglone affects mitochondrial energy metabolism (Makawiti
et al., 1990) it should also affect ATP-dependent pathways, such as
gluconeogenesis and ureogenesis. Figs. 3A and B show results of
experiments in which the action of juglone on lactate gluconeogene-
sis was measured. Livers from 18 h fasted rats were used in order to
minimize interference by glycogen catabolism. Fig. 3A illustrates the
response of the perfused liver to juglone infusion at the concentration
of 50 μM and it also represents a typical experimental protocol. After
a pre-perfusion period of 10 min in the absence of substrate, 2 mM
lactate was infused during 20 min, followed by additional 30 min of
juglone plus lactate infusion. In the absence of juglone the infusion
Fig. 2. Actions of juglone in glycogen catabolism and oxygen uptake. Livers from fed rats were perfused as described in the Materials and methods section. The efﬂuent perfusate
was sampled in 4-min intervals and analyzed for glucose, lactate, and pyruvate. Oxygen consumption was followed polarographically. Panel A shows the time course of experiments
in which 50 μM juglone was infused as indicated. In the graphs of panels B and C the concentration dependences of the effects of juglone on oxygen uptake, glycogenolysis, glycolysis
(panel B) and the lactate to pyruvate ratio (panel C) were represented. Values of the parameters at the end of juglone infusion (40 min perfusion time) were represented.
Glycogenolysis and glycolysis are expressed as glucosyl units andwere calculated as: glucose production+1/2(lactate+pyruvate production) and lactate+pyruvate production, respec-
tively. Eachdatumpoint represents themeans of 3–4 liver perfusion experiments. Bars are standard errors of themean. Asterisks and crosses indicate statistical signiﬁcance in comparison
with the control condition as revealed by variance analysis with post hoc Student-Newman–Keuls testing (+ pb0.05, ** pb0.01, * pb0.001).
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glucose production and oxygen uptake. The infusion of 50 μM juglone
caused a progressive and, at the end, very strong decrease in glucose
production. No recovery occurred during the 20 min following cessa-
tion of the drug infusion. Initially no changes in oxygen consumption
were apparent when the juglone infusion was started. Inhibition,
however, begun to occur at 54 min perfusion time. This inhibitory
trend was maintained after cessation of juglone infusion. Fig. 3B
allows an evaluation of the effects of several juglone concentrations
on oxygen uptake and glucose production from lactate in the range
of 5.0–50 μM. The ﬁnal values observed at the end of the juglone infu-
sion period (60 min perfusion time) were represented against the
juglone concentrations. Glucose production was inhibited over the
whole range of the juglone concentrations. Numerical interpolation
revealed 50% inhibition at the juglone concentration of 14.9 μM.
Oxygen uptake, on the other hand, was stimulated by juglone up to
20 μM, with maximal stimulation at 5 μM. Inhibition occurred at
50 μM, as also shown in Fig. 3A.
Alanine gluconeogenesis was also investigated. This substrate
induces a more oxidized state when compared to lactate and the
transfer of the amine group also inﬂuences the urea cycle and several
related pathways. Fig. 4A shows the effects of 50 μM juglone on the
carbon ﬂuxes and oxygen uptake due to alanine infusion whereas
Fig. 4B illustrates the changes in the nitrogen ﬂuxes. The infusion of
2.5 mM alanine caused a rapid increase in glucose production and
oxygen uptake (Fig. 4A). The subsequent infusion of 50 μM juglone
was strongly inhibitory for glucose production. Oxygen consumption
underwent an initial transitory increase that was reversed to inhibi-
tion at 60 min perfusion time (Fig. 4A). Finally, 50 μM juglone strong-
ly stimulated lactate and pyruvate production. The nitrogen ﬂuxes
were also affected (Fig. 4B). Ammonia and glutamate production
were both clearly stimulated by the drug. Urea production underwentan initial transitory increase, which was followed by inhibition. The
concentration dependences of the juglone effects on alanine metabo-
lism are shown in Fig. 5. Inhibition of glucose production presents a
clear concentration dependence, with 50% inhibition at the concen-
tration of 15.7 μM. Stimulations of ammonia and glutamate produc-
tions were saturable functions of the juglone concentration in the
range up to 50 μM, with half-maximal stimulations at 4.15 and 5.1
μM, respectively. Lactate and urea production were stimulated in
the range up to 20 μM, with a declining tendency at 50 μM. Oxygen
uptake was also stimulated by juglone up to 20 μM, but diminished
to values below the basal ones at the concentration of 50 μM. Pyru-
vate production, ﬁnally, was stimulated over the whole concentration
range with a parabolic dependence.
For the sake of comparison the experiments with alanine as the sub-
strate were repeated using the classical uncoupler 2,4-dinitrophenol
(experiments not shown). The effects of this compound were similar
to the actions of juglone. Gluconeogenesis was 50% inhibited at a con-
centration of 17.9 μM. Ammonia release and urea production were
also stimulated by 2,4-dinitrophenol, with half-maximal effects at
4.55 and 4.76 μM, respectively.
Effects of juglone on transaminases and tissue contents of
α-ketoglutarate and glutamate
Although it inhibits gluconeogenesis from alanine, juglone
increases all other parameters, notably glutamate and ammonia pro-
duction. This indicates an overall increase in alanine transformation.
Increased alanine transformation necessarily requires increased ala-
nine aminotransferase (ALT) activities in the cytosol. For this reason
the action of juglone on this enzyme from liver homogenates
was measured. No effects, however, were detected in the range up to
50 μM after four determinations (control, 0.19±0.01 and 50 μM juglone,
Fig. 3. Effects of juglone on gluconeogenesis from lactate in perfused livers isolated
from fasted rats. Livers from fasted rats were perfused as described in the Materials
and methods section. Lactate (2 mM) and juglone were infused as indicated by the hor-
izontal bars in panel A, which shows the time course of the changes caused by 50 μM
juglone in glucose production and oxygen consumption. Panel B shows the concentra-
tion dependence of the effects of juglone on oxygen consumption and gluconeogenesis.
The experimental protocol was the same for all juglone concentrations. Values of the
parameters at the end of juglone infusion (60 min perfusion time) were represented.
Each datum point is the mean of 4 experiments. Asterisks and crosses indicate statistical
signiﬁcance in comparison with the control condition as revealed by variance analysis
with post hoc Student-Newman–Keuls testing (+ pb0.05, ** pb0.01, * pb0.001).
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on the activity of aspartate aminotransferase (AST; control, 0.29±0.01
and 50 μM juglone, 0.28±0.06 μmol min−1 mg protein−1).
In the absence of direct effects on alanine aminotransferase, an
increased ﬂux through this enzyme in the cell can be caused by
increased concentrations of α-ketoglutarate, the second substrate of
the enzyme. Fig. 6 shows the results of experiments in which the
tissue contents of α-ketoglutarate and L-glutamate were measured
in the presence of alanine alone and in the simultaneous presence
of alanine and juglone at two different concentrations, 20 and
50 μM. The graph in Fig. 6 reveals a very pronounced increase in the
hepatic α-ketoglutarate content in the presence of both 20 and
50 μM juglone. The glutamate content, however, was not signiﬁcantly
increased by 20 μM juglone and even diminished by 50 μM juglone.Effects of juglone on the hepatic contents of adenine mono- and
dinucleotides
Measurement of the adenine mono- and dinucleotide levels under
the gluconeogenic conditions induced by alanine can perhaps be
helpful in the interpretation of the effects of juglone. Table 1 lists
the results found using livers from fasted rats in the presence of
2.5 mM alanine alone and in the simultaneous presence of 20 μMjuglone. It is apparent that 20 μM juglone reduced the levels of ATP
and increased those of ADP and AMP. Consequently, the ATP/ADP
and ATP/AMP ratios were also reduced by 37% and 60%, respectively.
Concerning the NAD+–NADH couple, 20 μM juglone signiﬁcantly
diminished the level of the oxidized form, but increased that of the
reduced form. In consequence, the NADH/NAD+ ratio was elevated
six-fold by juglone.
Effects of juglone on respiration and on membrane-bound enzymatic
activities of isolated rat liver mitochondria
The effects of juglone on the respiratory activity of isolated mito-
chondria were investigated in the concentration range between 1 and
10 μM. Succinate and β-hydroxybutyrate were used as substrates in
the presence or absence of ADP. The respiration rates were measured
under three conditions: a) before the addition of ADP (substrate respi-
ration), b) just after ADP addition (state III respiration) and c) after ces-
sation of the ADP stimulation (state IV respiration). With succinate as
the substrate (Fig. 7A) juglone increased gradually in a concentration
dependent manner both substrate and state IV respiration but dimin-
ished state III respiration. When β-hydroxybutyrate was the substrate
(Fig. 7B), state III respiration was also diminished, but to a higher
degree. Substrate respiration and state IV respiration, however,
tended to increase at low concentrations and to decrease at higher
concentrations.
Table 2 shows the effects of juglone on the ADP/O and respiratory
control ratios (RC). As noted, juglone reduced signiﬁcantly the ADP/O
ratio already at the concentration of 1 μM when β-hydroxybutyrate
was the substrate. At the concentration of 5 μM the ADP/O ratio
could no longer be determined. The respiratory control ratio was
also reduced and eventually abolished, depending on the concentra-
tion. Similar results were obtained when succinate was the substrate,
but at somewhat higher concentrations.
The uncoupling action of juglone was further investigated by
measuring the ATPase, NADH-oxidase and succinate-oxidase activities
of rat livermitochondria. The ATPase activitywasmeasured usingmito-
chondria under three different conditions: intact (coupled), freeze-
thawing disrupted and 2,4-dinitrophenol uncoupled. Fig. 8A shows
that theATPase activitywas stimulated by juglone in the range between
1 and 10 μM, but with a maximum at 2.5 μM. The ATPase activity of dis-
rupted and uncoupled mitochondria, however, was relatively insensi-
tive to juglone in the range up to 2.5 or 5 μM, and inhibited at higher
concentrations. The actions of juglone on the NADH- and succinate-
oxidase activities are shown in Fig. 8B. The NADH-oxidase activity was
stimulated at concentrations between 5 and 10 μM; the succinate-
oxidase activity, however, was not signiﬁcantly affected.
Discussion
The main conclusion that can be drawn from the bulk of the data
obtained in the present work is that juglone is active on liver metab-
olism and able to affect several metabolic routes which are linked in
some way to energy metabolism. In general, most observations in
the perfused liver are compatible with its reported uncoupling action.
The most important observations, which have also been traditionally
reported for other uncouplers of oxidative phosphorylation are:
a) stimulation of oxygen consumption at low concentrations (Soboll
et al., 1978; Suzuki-Kemmelmeier and Bracht, 1989); b) diminution
of the ATP content combined with diminutions in the ATP/ADP and
ATP/AMP ratios (Soboll et al., 1978); c) increase in the NADH/NAD+
ratio (Soboll et al., 1978; Suzuki-Kemmelmeier and Bracht, 1989);
d) inhibition of gluconeogenesis (Kelmer-Bracht and Bracht, 1993;
Suzuki-Kemmelmeier and Bracht, 1989) from two different sub-
strates, namely lactate and alanine; e) stimulation of glycolysis as a
cytosolic compensatory phenomenon for the diminished mitochon-
drial ATP production (Soboll et al., 1978; Suzuki-Kemmelmeier and
Fig. 4. Time courses of the effects of 50 μM juglone on alanine metabolism. Livers from fasted rats were perfused as described in the Materials and methods section. Alanine
(2.5 mM) and juglone were infused as indicated. Oxygen uptake (panel A) was measured polarographically in the efﬂuent perfusate. Samples of the efﬂuent perfusate were collect-
ed for the enzymatic assay of pyruvate, lactate, glucose (panel A), glutamate, ammonia and urea (panel B). Each datum point is the mean±SEM of 4 liver perfusion experiments.
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ing glucose 6-phosphate for the increased glycolytic ﬂux (Lopez et
al., 1998; Soboll et al., 1978).Fig. 5. Concentration dependence of the effects of juglone on parameters dependent on
alanine metabolism. The experimental protocol was the same illustrated by Fig. 4. Each
datum point is the mean of 4 experiments. Values of the parameters at the end of
juglone infusion (60 min perfusion time in Fig. 4) were represented. Asterisks and
crosses indicate statistical signiﬁcance in comparison with the control condition as
revealed by variance analysis with post hoc Student-Newman–Keuls testing (+ pb0.05,
** pb0.01, * pb0.001).Experiments with isolated mitochondria, based on the original
observations of Makawiti et al. (1990), allowed to characterize fur-
ther the actions of juglone on the organelle. The uncoupling action
of juglone was fully corroborated by the diminished ADP/O and respi-
ratory control ratios as well as by the stimulated ATPase activity in
intact mitochondria. It must be remarked, however, that in disrupted
mitochondria and in mitochondria that were previously uncoupled by
the addition of 2,4-dinitrophenol, juglone promoted inhibition of the
ATPase activity at concentrations above 5 μM. This suggests an addi-
tional effect for the compound, namely inhibition of the ATP-
synthase. This conclusion is further corroborated by the observation
that state III respiration was inhibited even at low concentrations.
Furthermore, in intact mitochondria, stimulation of the ATPaseFig. 6. Inﬂuence of juglone on the hepatic content of glutamate and α-ketoglutarate.
Livers from fasted rats were perfused with 2.5 mM alanine and juglone as described
in Material and methods. At 60 min perfusion time (see Fig. 4) the perfused livers
were clamped in liquid nitrogen and extracted with perchloric acid. The neutralized
extracts were used for glutamate and α-ketoglutarate enzymatic assay. Values are
the means±SEM for 4 perfusion experiments. Asterisks and crosses indicate statistical
signiﬁcance in comparison with the control condition as revealed by variance analysis
with post hoc Student-Newman–Keuls testing (** pb0.01, + pb0.05).
Table 1
Inﬂuence of juglone on hepatic contents of adenine mono- and dinucleotides in the
presence of 2.5 mM alanine.
Parameter Control (n=5) 20 μM juglone (n=5)
μmol×(g liver wet weight)−1
ATP 1.704±0.095 1.389±0.076⁎
ADP 0.622±0.042 0.794±0.053⁎
AMP 0.246±0.046 0.442±0.066⁎
ATP+ADP+AMP 2.571±0.170 2.626±0.165
NAD+ 0.457±0.042 0.332±0.016⁎
NADH 0.007±0.001 0.040±0.010⁎
Ratios
ATP/ADP 2.766±0.151 1.766±0.102⁎
ATP/AMP 7.923±1.292 3.354±0.392⁎
NADH/NAD+ 0.017±0.001 0.119±0.029⁎
Livers from fasted rats were perfused in an open system as described in the Materials
and methods section. Alanine (2.5 mM) was infused at 10 min and juglone (20 μM)
was infused 20 min after alanine infusion for 30 min. The livers were freeze-clamped
in liquid nitrogen and the adenine nucleotides were extracted with cold perchloric
acid (with alkali for NADH determination). Control determinations were done with
livers that were freeze-clamped at the same perfusion time in the presence of
alanine but without juglone infusion. Values are means±SEM.
⁎ pb0.05.
Table 2
Actions of juglone on the mitochondrial respiration driven by succinate or β-hydroxy-
butyrate in the presence and absence of exogenously added ADP.
Juglone (μM) β-Hydroxybutyrate (n=8) Succinate (n=8)
ADP/O ratio Respiratory
control ratio
ADP/O ratio Respiratory
control ratio
0 3.73±0.20 3.51±0.17 2.55±0.15 3.96±0.22
1 2.85±0.16⁎ 2.83±0.18⁎ 2.28±0.10⁎ 3.67±0.27
2.5 2.77±0.13⁎ 1.80±0.26⁎ 1.98±0.12⁎ 2.31±0.27⁎
5 –a 1.31±0.14⁎ 1.71±0.15⁎ 2.31±0.29⁎
7.5 –a 1.82±0.07⁎ –a 1.50±0.15⁎
10 –a 1.00±0.00⁎ –a 1.30±0.12⁎
Mitochondria were isolated and assayed as described in the Materials and methods
section. Incubations were done in the presence of substrate (10 mM) as indicated.
Values are means±SEM.
⁎ Statistically signiﬁcant relative to the controls (variance analysis with post hoc
Newman–Keuls esting; pb0.05).
a Very low value, no accurate determination possible.
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This kind of response is normally observed when two opposite effects
are present (Kelmer-Bracht et al., 1985). It should be noted that the
inhibitory effect at higher concentrations was also found in the intactFig. 7. Effects of juglone on the respiratory activity of isolated rat liver mitochondria.
Mitochondria (0.25–2.5 mg/mL) were added to the reaction medium in the closed
vessel of the oxygraph. The reaction was initiated by the addition of succinate (panel
A) or β-hydroxybutyrate (panel B) and the oxygen consumption was followed polaro-
graphically for 5 min. After this time 0.25–0.5 nmol of ADP was added. Rates of oxygen
consumption were computed from the slopes of the polarographic records. Each datum
point is the mean±SEM of 6 independent experiments. Asterisks indicate statistical
signiﬁcance in comparison with the control condition as revealed by variance analysis
with post hoc Student-Newman–Keuls testing (pb0.05).cells: under several experimental conditions inhibition of oxygen
consumption by the liver was found at the highest juglone concentra-
tions, especially under gluconeogenic conditions. Concerning the
enzymatic systems responsible for electron ﬂow in the respiratory
chain, juglone did not inhibit succinate-oxidase but, surprisingly,Fig. 8. Effects of juglone on mitochondrial membrane-bound enzymatic activities. The
experiments in panel A (ATPase activity) were done with intact mitochondria and
those in panel B (succinate and NADH oxidases) with freeze-thawing disrupted mito-
chondria. The mitochondria were incubated at 37 °C in reaction media described in
the Materials and methods section. Each datum point represents the mean±SEM of
6 experiments. Asterisks indicate statistical signiﬁcance in comparison with the control
condition as revealed by variance analysis with post hoc Student-Newman–Keuls testing
(pb0.05).
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latter phenomenon could be contributing for the stimulation of oxy-
gen uptake in the intact liver. No mechanistic explanation for this ef-
fect can be drawn from our experimental data.
The experiments with alanine as the substrate allowed us to
examine in more detail the action of uncouplers on nitrogen metabo-
lism. To our knowledge, there are no reports in which this aspect has
been analyzed more extensively in the intact liver cell although some
indications can be drawn from experiments with isolated mitochon-
dria. The scheme in Fig. 9 summarizes some of the events related to
alanine metabolism that will be discussed here. The scheme shows
several enzyme catalyzed transformations but it also emphasizes
the compartmentation of both α-ketoglutarate and L-glutamate
(Soboll et al., 1980). In isolated mitochondria it has been found
that uncouplers increase L-glutamate deamination which leads to α-
ketoglutarate production (Nilova, 1977; Quagliariello et al., 1965).
Uncouplers also increase the tricarboxylic acid cycle where the mito-
chondrial isocitrate dehydrogenases (NAD+ and NADP+-dependent)
can transform isocitrate into α-ketoglutarate. Consistent with these
notions about the mitochondrial metabolism, we found increased
cellular levels of α-ketoglutarate during juglone infusion. Alpha-
ketoglutarate can also be produced in the cytosol by the cytosolic iso-
citrate dehydrogenase as shown in Fig. 9. There is a recent suggestion
that this might even be the most important route for α-ketoglutarate
production (Rokhmanova and Popova, 2006) but there are not data
about the action of uncouplers on this event. The increased levels of
α-ketoglutarate are the most probable cause for the increased rates
of alanine transformation caused by juglone. The latter phenomenon
is indicated by the increased release of ammonia and urea caused by
the drug, in spite of the reduced rates of glucose production. In the ab-
sence of any direct effect of juglone on the alanine aminotransferase
(ALT), the only possibility for enhancing alanine deamination in the
presence of a constant concentration of this amino acid is to raise the
concentration of the second substrate of this enzyme, which is α-
ketoglutarate. It should be added that no short-term regulation mecha-
nism for ALT is known.
The increase in L-glutamate release caused by juglone must be
examined in terms of the characteristics of the pertinent transport
system. Transport of L-glutamate into the cell is of the concentrative
type. The cellular concentration of L-glutamate is generally much
higher than the extracellular concentration. In our experiments, for
example, a L-glutamate production rate of 0.39 μmol min−1 g−1
corresponds to a mean portal-venous concentration of 0.05 mM,
whereas the cellular content reaches 0.5 mM. The high-afﬁnity gluta-
mate transporters mediate transport of L-glutamate by the cotransportFig. 9. Schematic representation of important events leading to the formation of am-
monia, aspartate and glutamate in consequence of alanine infusion. Symbols: Ala, ala-
nine; Pyr, pyruvate; Lac, lactate; α-KetoC, cytosolic α-ketoglutarate; GluC, cytosolic L-
glutamate; α-KetoM, mitochondrial α-ketoglutarate; GluM, mitochondrial L-glutamate;
Asp, aspartate; OXAL, oxaloacetate; TCA, tricarboxylic acid cycle; ALT, alanine amino-
transferase; AST, aspartate aminotransferase; IcitrC, cytosolic isocitrate; LDH, lactate
dehydrogenase; IDHC, cytosolic isocitrate dehydrogenase; IDHM, mitochondrial isoci-
trate dehydrogenase; GluDH, glutamate dehydrogenase. The thick arrows indicate
the steps that can be directly stimulated by uncouplers.of 3 Na+ and 1 H+, and the countertransport of 1 K+ (Kanai and
Hediger, 2004; Mann et al., 2003). It is this coupling that allows uphill
transport of glutamate into cells against a concentration gradient.
Consequently, it would not be surprising if uncoupling, which changes
the membrane permeability to H+, causes an increased leakage of
L-glutamate because the inward directed concentration gradient
cannot be maintained. Furthermore, the coupling is ultimately energy-
dependent, which under energy deﬁcient conditions can also be im-
paired. This would explain the increased rates of L-glutamate release
in the presence of juglone even in the absence of increased cellular con-
centrations. On the other hand, compartmentation of L-glutamate could
equally play some role. Soboll et al. (1980) have shown that L-glutamate
is present at different concentrations in the cytosol and in the mito-
chondria. In the liver of fasted rats under substrate-free perfusion, for
example, the cytosolic and mitochondrial concentration of L-glutamate
are 2.65 and 0.65 mM, respectively. It could be that in our experiments,
the cytosolic concentration of L-glutamatewas raised by juglonewhere-
as the mitochondrial one was decreased in such a way that the total
content of the liver cells remained more or less the same. This is a real
possibility if one takes into account the fact that uncoupling stimulates
L-glutamate deamination in themitochondria (Quagliariello et al., 1965;
Nilova, 1977; see Fig. 9) a phenomenon that tends to decrease the
mitochondrial concentration. The opposite occurs in the cytosol where
the L-glutamate concentration can be expected to increase by virtue of
the increased α-ketoglutarate concentration which increases the rate
of the ALT reaction.
A ﬁnal point to be discussed is one concerned with the signiﬁcance
of the effects that were observed in the present work which are
potentially toxic to animals. In nature it is known that juglone retards
the growth of competing plants under walnut trees (Jose and Gillispie,
1998). Since uncouplers usually break down the proton electrochemical
gradient in chloroplasts in the same way as in mitochondria, this could
be the likely reason why juglone is also toxic to plants. Juglone is
unavoidably ingested by humans when walnut extracts are used in pop-
ularmedicine and it isworth to examine how this could affect the general
physiology (Bell, 1981; Jin, 2010;Mahoney et al., 2000). Uncouplers were
used in the past as weight loss agents, especially 2,4-dinitrophenol. Since
uncouplers reduce the efﬁciency of energy transduction in themitochon-
drial electron transport chain,more fuel has to beoxidized in order to pro-
duce the same amount of ATP. This fuel comprises largely fatty acids,
weight loss is thus an understandable effect of uncoupling agents. Most
of them are quite dangerous due to their narrow therapeuticwindow, i.e.,
the small concentration range between mild and nearly full uncoupling.
The latter is a highly toxic condition. It has been proposed that uncouplers
with a wide therapeutic window would be more appropriate and less
dangerous as therapeutic agents for weight loss (Lou et al., 2007). One
such compound is 2,6-bis(1,1-dimethylethyl)-4-methylphenol, more
commonly known as BHT. This compound already uncouples at extreme-
ly low concentrations, 2×10−12 M, but it produces onlymodest increases
in uncoupling as its concentration is raised to 2 μM(Lou et al., 2007).Most
other uncouplers, including 2,4-dinitrophenol show a much narrower
range of activity, generally comprising not much than one order of mag-
nitude. From the results obtained in the present work it is evident that
juglone must be classiﬁed as a narrow range uncoupler. In isolated mito-
chondria its action is exerted in the 10−6 to 10−5 M range. In the per-
fused liver, the consequences of this action are detectable in the 10−6 to
2×10−5 M range. In this particular, thus, it resembles more closely the
classical uncoupler 2,4-dinitrophenol. Ingestion of high doses of juglone,
consequently, presents the same risks as the ingestion of high doses of
2,4-dinitrophenol which comprise excessive compromising of ATP pro-
duction, hyperthermia and even death. It should also be noted that block-
ing of transcription, induction of DNA damage, reduction of protein levels
and induction of cell death are all effects that occur within the same con-
centration range as the effects observed in the presentwork (Paulsen and
Ljungman, 2005). The use of juglone as an anticancer agent, thus, is not
deprived of considerable risk if one takes into account the doses that are
327S.C. Saling et al. / Toxicology and Applied Pharmacology 257 (2011) 319–327necessary for this action. On the other hand, there are recent reports
showing that mild uncoupling could have beneﬁcial effects because in
medium term the increased energy expenditure and oxygen consump-
tion causes little or no changes in the ATP levels. Mild uncoupling appar-
ently trigers molecular mechanisms that are able to increase both
mitochondrial gene expression and mitochondrial volume (Rohas et al.,
2007). In agreement with these observations it has also been shown
that mild uncoupling increases longevity in mice a phenomenon that
was associated with the improvement of several serological markers
such as glucose, triglycerate and insulin levels (Caldeira da Silva et al.,
2008). These observations suggest that moderate consumption of natural
products containing juglone can be beneﬁcial to health especially during
aging.
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